Total Payments
$24,910
2024 Payments
$1,048
Companies
24
Transactions
322
Medicare Patients
1,233
Medicare Billing
$233,885
Payment Breakdown by Category
Other$16,147 (64.8%)
Food & Beverage$7,779 (31.2%)
Travel$970.33 (3.9%)
Education$13.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,147 | 14 | 64.8% |
| Food and Beverage | $7,779 | 298 | 31.2% |
| Travel and Lodging | $970.33 | 9 | 3.9% |
| Education | $13.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $18,333 | 57 | $0 (2024) |
| ABBVIE INC. | $1,470 | 87 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,108 | 30 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $685.80 | 34 | $0 (2024) |
| Neuronetics, Inc. | $603.53 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $513.63 | 19 | $0 (2023) |
| Alkermes, Inc. | $395.21 | 15 | $0 (2024) |
| ITI, Inc. | $339.39 | 12 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $266.03 | 14 | $0 (2024) |
| Axsome Therapeutics, Inc. | $196.35 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,048 | 50 | Teva Pharmaceuticals USA, Inc. ($258.88) |
| 2023 | $1,604 | 76 | AbbVie Inc. ($402.38) |
| 2022 | $1,169 | 64 | ABBVIE INC. ($458.93) |
| 2021 | $708.10 | 33 | AbbVie Inc. ($408.23) |
| 2020 | $361.47 | 14 | Neuronetics, Inc. ($98.51) |
| 2019 | $4,134 | 21 | Otsuka America Pharmaceutical, Inc. ($3,498) |
| 2018 | $8,123 | 31 | Otsuka America Pharmaceutical, Inc. ($7,436) |
| 2017 | $7,762 | 33 | Otsuka America Pharmaceutical, Inc. ($7,128) |
All Payment Transactions
322 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Neuropsychiatry | ||||||
| 10/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: Central Nervous System | ||||||
| 09/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: CNS | ||||||
| 09/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: Central Nervous System | ||||||
| 07/09/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Central Nervous System | ||||||
| 06/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Neuropsychiatry | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Neuropsychiatry | ||||||
| 06/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Central Nervous System | ||||||
| 05/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: CNS | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: Central Nervous System | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Central Nervous System | ||||||
| 04/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 167 | 383 | $43,559 | $30,981 |
| 2022 | 7 | 265 | 556 | $66,955 | $47,742 |
| 2021 | 7 | 393 | 979 | $108,165 | $82,111 |
| 2020 | 8 | 408 | 951 | $115,246 | $73,051 |
Total Patients
1,233
Total Services
2,869
Medicare Billing
$233,885
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 151 | $19,131 | $12,623 | 66.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 130 | $10,149 | $7,780 | 76.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 55 | $9,392 | $6,962 | 74.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 29 | 31 | $3,487 | $2,602 | 74.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 16 | $1,401 | $1,013 | 72.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 176 | $22,761 | $16,113 | 70.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 84 | 91 | $18,584 | $13,244 | 71.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 194 | $14,248 | $10,425 | 73.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 37 | $3,909 | $2,926 | 74.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 17 | 17 | $3,392 | $2,534 | 74.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 27 | $2,599 | $1,365 | 52.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 14 | $1,463 | $1,135 | 77.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 73 | 405 | $29,344 | $23,210 | 79.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 109 | 131 | $26,546 | $19,377 | 73.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 174 | $22,588 | $16,799 | 74.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 56 | 137 | $14,201 | $11,000 | 77.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 64 | 78 | $8,286 | $6,386 | 77.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 18 | 18 | $3,615 | $2,854 | 79.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 36 | $3,585 | $2,484 | 69.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 83 | 425 | $35,876 | $24,066 | 67.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 116 | 136 | $32,524 | $20,959 | 64.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 144 | $13,027 | $7,575 | 58.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 85 | $10,750 | $6,289 | 58.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 49 | 68 | $8,673 | $5,317 | 61.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 51 | 59 | $8,073 | $4,858 | 60.2% |
About Dr. Jordan Brown, M.D
Dr. Jordan Brown, M.D is a Psychiatry healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2012. The National Provider Identifier (NPI) number assigned to this provider is 1346500998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jordan Brown, M.D has received a total of $24,910 in payments from pharmaceutical and medical device companies, with $1,048 received in 2024. These payments were reported across 322 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,147).
As a Medicare-enrolled provider, Brown has provided services to 1,233 Medicare beneficiaries, totaling 2,869 services with total Medicare billing of $233,885. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Gainesville, FL
- Active Since 05/16/2012
- Last Updated 05/16/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346500998
Products in Payments
- ABILIFY MAINTENA (Drug) $17,891
- VRAYLAR (Drug) $1,594
- LATUDA (Drug) $1,108
- NEUROSTAR TMS THERAPY (Device) $494.39
- CAPLYTA (Drug) $457.59
- Austedo XR (Drug) $403.14
- REXULTI (Drug) $355.79
- INVEGA SUSTENNA (Drug) $354.99
- ARISTADA (Drug) $336.03
- INGREZZA (Drug) $266.03
- SPRAVATO (Drug) $259.25
- Auvelity (Drug) $196.35
- AUSTEDO (Drug) $159.11
- TRINTELLIX (Drug) $154.01
- NUPLAZID (Drug) $115.56
- BELSOMRA (Drug) $100.14
- NeuroStar TMS Therapy (Device) $75.14
- UZEDY (Drug) $74.86
- QUVIVIQ (Drug) $63.69
- APLENZIN (Drug) $52.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Gainesville
Lawrence Reccoppa, Md, MD
Psychiatry — Payments: $931,545
Psychiatry $931,545
Shahzad Hashmi, M.d.,, M.D.,
Psychiatry — Payments: $65,221
Psychiatry $65,221
Dr. Wayne Goodman, Md, MD
Psychiatry — Payments: $25,379
Psychiatry $25,379
Dr. Amparo Benitez-Broome, D.o, D.O
Psychiatry — Payments: $9,518
Psychiatry $9,518
Mrs. Lisa Wirth, Md, MD
Psychiatry — Payments: $8,749
Psychiatry $8,749
Dr. Kenneth Goolsby, M.d, M.D
Psychiatry — Payments: $7,746
Psychiatry $7,746